Management of hepatocellular carcinoma prior to liver transplantation: latest developments
Hepatocellular carcinoma (HCC) is a highly morbid malignancy that is a leading cause of death in patients with cirrhosis or chronic hepatitis B. Liver transplantation is considered a curative therapy for HCC, with 5-year survival rates exceeding 75%. Current allocation policy in the US restricts tra...
Saved in:
| Main Authors: | Antoine Robert, Thomas M. Hunold, Neehar D. Parikh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis
2025-12-01
|
| Series: | Hepatic Oncology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20450923.2025.2549676 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01) -
Health Outcomes and Resource Consumption Analysis of Radioembolization with Y90 Glass Microspheres (TARE-Y90) Versus Transarterial Chemoembolization with Irinotecan (DEBIRI) in Patients with Liver Metastases from Colorectal Cancer in Spain
by: Juan José Ciampi-Dopazo, et al.
Published: (2025-03-01) -
Identifying Subgroup at High Risk of Transarterial Chemoembolization Failure Among Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
by: Edoardo Poli, et al.
Published: (2025-02-01) -
Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation
by: Sofia Lopiano, et al.
Published: (2025-05-01) -
Hepatogastric fistula formation after liver chemoembolization in a patient with hepatocellular carcinoma
by: S. A. Ivanov, et al.
Published: (2023-03-01)